Shittu Olalere, Opeyemi Olufunke Adenike, Ajibaye Olusola, Omotesho Babagbemi Olumuyiwa, Fakayode Oluwatosin
Parasitology Unit, Department of Zoology, University of Ilorin, Ilorin, Nigeria.
Biochemistry and Nutrition Unit, Nigeria Institute of Medical Research, Lagos, Nigeria.
Open Access Maced J Med Sci. 2018 Jun 5;6(6):1032-1040. doi: 10.3889/oamjms.2018.218. eCollection 2018 Jun 20.
Accurate laboratory diagnosis of suspected malaria is the hallmark to the control of the disease.
The clinical proficiency of commercial Rapid Diagnostic test kits (RDTs) using nested PCR as quality control was evaluated among patients attending two public healthcare providing institutions in Ilorin, Kwara state, North-Central, Nigeria.
A cross-sectional evaluation of finger prick blood samples of volunteer patients were accessed for malaria parasites with pLDH, HRP2, Pf, Pf/PAN and nested PCR molecular assays. The data derived were analysed using standard formulae for diagnostic accuracy, and the obtained predictive values were subjected to a comparison with one-way analysis of variance (ANOVA).
Three hundred and sixty-eight (368) patients comprising 203 (55%) females and 165 (45%) males participated in this study. Routine microscopy revealed that 54 (32.7%) males and 80 (39.4%) was infected with Plasmodium falciparum. SD Bioline (pLDH) 47.4%; Carestart Malaria (HRP2) 49.8% recorded low sensitivities. Micropoint (pfPAN) 82.8% and Micropoint (Mal. Pf) 64.4% recorded a high sensitivity. SD Bioline (pLDH) 67.4%; Carestart Malaria (HRP2) 85.9%; Micropoint (PfPAN) 62.2% and Micropoint (Mal. Pf) 86.7% had high specificities. The positive predictive value (PPV) ranged from 67.7% to 85.94%, while the negative predictive values (NPV) of 64.4% for SD Bioline (pLDH); 86.7% for Carestart Malaria (HRP2); 89.3% for Micropoint (pfPAN) and 58.5% for Micropoint (Mal. Pf). Agarose gel analysis of gene (206 bp) for 28 specimens containing 10% concordant and discordant samples showed that all 12 negative specimens for RDTs and routine microscopy were truly negative for nPCR. However, the remaining 16 specimens were positive for nPCR and showed discrepancies with routine microscopy and RDTs. Cohen's interrater diagnostic measure analysis revealed that the weighted kappa for the RDTs was moderate 0.417 (p=0.027), 95%CI (0.756, 0.078) and good for nPCR 0.720 (p < 0.001), 95%CI (0.963, 0.477). The area under the curve (AUC) specify that nPCR has been more effective than the RDTs (nPCRAUC = 0.875; p < 0.001 and RDTsAUC = 0.708; p = 0.063).
A thorough large-scale quality control is advocated on all commercial RDTs being used in most sub-Saharan African countries. This is to avoid double jeopardy consequent upon misdiagnosis on unidentified positive cases serving as pool reservoir for the insect vector and cyclical infection and re-infection of the populace.
对疑似疟疾进行准确的实验室诊断是控制该疾病的关键。
在尼日利亚中北部夸拉州伊洛林的两家公共医疗机构就诊的患者中,评估以巢式聚合酶链反应(nested PCR)作为质量控制的商用快速诊断检测试剂盒(RDTs)的临床效能。
采用pLDH、HRP2、Pf、Pf/PAN和巢式PCR分子检测法,对自愿参与的患者的手指刺血样本进行疟疾寄生虫检测。采用标准公式分析所得数据的诊断准确性,并将获得的预测值进行单因素方差分析(ANOVA)比较。
368名患者参与了本研究,其中203名(55%)为女性,165名(45%)为男性。常规显微镜检查显示,165名男性中有54名(32.7%)、203名女性中有80名(39.4%)感染了恶性疟原虫。SD Bioline(pLDH)的敏感性为47.4%;Carestart Malaria(HRP2)的敏感性为49.8%,均较低。Micropoint(pfPAN)的敏感性为82.8%,Micropoint(Mal. Pf)的敏感性为64.4%,均较高。SD Bioline(pLDH)的特异性为67.4%;Carestart Malaria(HRP2)的特异性为85.9%;Micropoint(PfPAN)的特异性为62.2%,Micropoint(Mal. Pf)的特异性为86.7%,均较高。阳性预测值(PPV)范围为67.7%至85.94%,而SD Bioline(pLDH)的阴性预测值(NPV)为64.4%;Carestart Malaria(HRP2)的阴性预测值为86.7%;Micropoint(pfPAN)的阴性预测值为89.3%,Micropoint(Mal. Pf)的阴性预测值为58.5%。对28份包含10%一致和不一致样本的标本进行的基因(206 bp)琼脂糖凝胶分析显示,RDTs和常规显微镜检查的所有12份阴性标本经巢式PCR检测均为真阴性。然而,其余16份标本经巢式PCR检测为阳性,与常规显微镜检查和RDTs结果存在差异。Cohen组内诊断测量分析显示,RDTs的加权kappa值为中度0.417(p = 0.027),95%置信区间(0.756,0.078),巢式PCR的加权kappa值为良好0.720(p < 0.001),95%置信区间(0.963,0.477)。曲线下面积(AUC)表明,巢式PCR比RDTs更有效(巢式PCRAUC = 0.875;p < 0.001,RDTsAUC = 0.708;p = 0.063)。
提倡对撒哈拉以南非洲大多数国家使用的所有商用RDTs进行全面的大规模质量控制。这是为了避免因对未识别的阳性病例误诊而导致双重危害,这些阳性病例可能成为昆虫媒介以及民众周期性感染和再感染的储存库。